Trivandrum: HLL Lifecare Ltd., a mini-ratna public sector undertaking with diversified business, is foraying into molecular diagnostics area with a duplex test kit to make Chikungunya and Dengue fever tests more affordable to the common man. The new multiplex molecular diagnostic kit has been developed by HLL in collaboration with the Rajiv Gandhi Centre for Biotechnology, also based in Thiruvananthapuram.
Currently, HLL Lifecare is in a tie-up with Kerala State Institute for Virology & Infectious Diseases, under the State Government’s Ministry of Health & Family Welfare Department, for third-party validation of the diagnostic kits. The product will be launched in the market very soon.
Dr. M Ayyappan, Chairman & Managing Director, HLL said, “Making public healthcare affordable has always been our motto. This kit, which is based on PCR (Polymerase Chain Reaction), comes as the latest offering from our portfolio to ease the burden of the common man. Further, the new product would facilitate conduct of the test with large throughput screening for management of diseases. It is going to be a handy tool in screening of patients on a large scale basis in an affordable manner.’’
The 1966 founded HLL, the leading manufacturer of condoms, is strong-footed in the diagnostic business with its Hindlabs that provide a complete range of path lab services. HLL has a factory located at Manesar in Haryana, exclusively catering to the manufacturing of in-vitro diagnostic test kits. This unit had started with manufacture of pregnancy test kits and is currently into production of kits for dengue and malaria, among other infectious diseases.
The PSU, which has diversified business divisions from condom to construction, is also in the diagnostic services segment with a network of pathlabs in the National Capital Region, besides three MRI Centres in Kerala (Alappuzha, Kottayam, Thrissur), Bangalore and Mumbai.
Kerala Biz News